PRNewsWire · INSM · October 19, 2026

Insmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan

Get the app for more

Explore stock news, insights and company research.